In a previous study, our group observed that 52.17% of DLBCL cases with BM involvement expressed an increased level of CD54, in contrast to normal mature B-cells, which expressed a low level of CD54 [25]. This evidence concerns the gene ICAM1 and diffuse large B-cell lymphoma.